SelectScience InterviewsClinical Diagnostics

Precision Medicine and the Future of Clinical Cancer Genomics

12 Aug 2019
Precision Medicine and the Future of Clinical Cancer Genomics

In this presentation at the European Society of Human Genetics (ESHG) conference 2019, Dr. Susie Cooke, Head of Genetics at Glasgow Precision Oncology Laboratory, University of Glasgow, UK, introduces Precision Panc, a UK-wide pancreatic cancer clinical trials network that translates cutting-edge concepts in cancer biology into genomic assays and analytical pathways. Cooke discusses the challenges and opportunities of applying high-throughput genomics to routine oncology care pathways and how this could influence the future of precision medicine.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Tags

Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Precision MedicinePrecision medicine refers to the idea of customized healthcare, where medical decisions and treatments are tailored to the individual patient. Molecular diagnostics, companion diagnostics and Next Generation Sequencing (NGS) play a pivotal role in this approach.
Precision Medicine and the Future of Clinical Cancer Genomics